Das Neueste aus der Oxalacetat-Forschung
New Double-Blind Clinical Trial: Oxaloacetate I...
A new randomized, double-blind clinical trial peer-reviewed and published by Frontiers in Neurology has demonstrated that oxaloacetate significantly improves cognitive function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), while also...
New Double-Blind Clinical Trial: Oxaloacetate I...
A new randomized, double-blind clinical trial peer-reviewed and published by Frontiers in Neurology has demonstrated that oxaloacetate significantly improves cognitive function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), while also...
New Research Suggests Oxaloacetate Supplementat...
Just published in the journal “Nature Microbiology” the article, “Oxaloacetate sensing promotes innate immune antiviral defence against influenza virus infection.” The article uncovers a new function of oxaloacetate supplementation—to promote...
New Research Suggests Oxaloacetate Supplementat...
Just published in the journal “Nature Microbiology” the article, “Oxaloacetate sensing promotes innate immune antiviral defence against influenza virus infection.” The article uncovers a new function of oxaloacetate supplementation—to promote...
AI Accelerates ME/CFS Research: A Milestone Wee...
It’s a sign that the scientific community is not only paying attention but is committed to accelerating progress for people living with ME/CFS. Integrating Multi-Omics Data for InsightFrom multi-omics modeling...
AI Accelerates ME/CFS Research: A Milestone Wee...
It’s a sign that the scientific community is not only paying attention but is committed to accelerating progress for people living with ME/CFS. Integrating Multi-Omics Data for InsightFrom multi-omics modeling...
Townsend Letter Report Follows International In...
Interest continues to grow in the scientific and medical communities for the potential of oxaloacetate medical food to provide relief for the millions struggling with ME/CFS and Long COVID. Following...
Townsend Letter Report Follows International In...
Interest continues to grow in the scientific and medical communities for the potential of oxaloacetate medical food to provide relief for the millions struggling with ME/CFS and Long COVID. Following...
Alan Cash präsentiert Ergebnisse klinischer Stu...
Alan Cash, Chief Science Officer von Oxaloacetate CFS, wird die neuesten klinischen Studiendaten zu Oxaloacetate CFS auf der virtuellen Forschungs- und Medizinkonferenz 2025 der International Association of Chronic Fatigue Syndrome/Myalgic...
Alan Cash präsentiert Ergebnisse klinischer Stu...
Alan Cash, Chief Science Officer von Oxaloacetate CFS, wird die neuesten klinischen Studiendaten zu Oxaloacetate CFS auf der virtuellen Forschungs- und Medizinkonferenz 2025 der International Association of Chronic Fatigue Syndrome/Myalgic...
Neue klinische Studie zu Long COVID zeigt, dass...
August 2025 – SAN DIEGO, CA – Eine neue randomisierte, doppelblinde, kontrollierte klinische Studie, die in Frontiers in Neuroscience veröffentlicht wurde , zeigt vielversprechende Ergebnisse für Oxalacetat-CFS , ein medizinisches...
Neue klinische Studie zu Long COVID zeigt, dass...
August 2025 – SAN DIEGO, CA – Eine neue randomisierte, doppelblinde, kontrollierte klinische Studie, die in Frontiers in Neuroscience veröffentlicht wurde , zeigt vielversprechende Ergebnisse für Oxalacetat-CFS , ein medizinisches...